Pro PG receives S19A approval for Cephalexin Capsules 500mg (Ascend USA)
Dear Healthcare Professional,
Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of CEFALEXIN SANDOZ cefalexin (as monohydrate) 500mg capsule blister pack in Australia.
The Australian registered medicine, CEFALEXIN SANDOZ cefalexin (as monohydrate) 500mg capsule blister pack (AUST R: 78980) is currently in shortage due to manufacturing issues.
Pro Pharmaceuticals Group has arranged for the supply of an alternative product, Cephalexin capsules, USP 500mg (Ascend). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 31st July 2023
Pre-Orders only at this stage and domestic delivery rates may apply
Registered Pro Pharm Member Pharmacies can Log into our website www.propg.com.au and visit Pharmacy Online Ordering to see Product Details including Pricing, Availability and also do any Pre-Orders.
Not a Registered Pro Pharm Member? Then Register Today by visiting our website and going to Pharmacy Online Ordering.
Please note Pro Pharmaceuticals Group is a Wholesaler and not a Pharmacy and can not supply to members of the Public, if you are a member of the Public please visit your Pharmacy to discuss.
